IntelliPharmaCeutics Intl (USA) (IPCI) Reaches $2.40 After 9.00% Down Move; Siteone Landscape Supply (SITE) Sellers Increased By 1.82% Their Shorts

July 5, 2017 - By Louis Casey

The stock of IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) is a huge mover today! About 286,186 shares traded or 130.58% up from the average. IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) has risen 16.57% since July 5, 2016 and is uptrending. It has underperformed by 0.13% the S&P500.The move comes after 7 months negative chart setup for the $86.83M company. It was reported on Jul, 5 by Barchart.com. We have $2.18 PT which if reached, will make NASDAQ:IPCI worth $7.81 million less.

Siteone Landscape Supply Incorporated (NYSE:SITE) had an increase of 1.82% in short interest. SITE’s SI was 2.58M shares in July as released by FINRA. Its up 1.82% from 2.53M shares previously. With 513,200 avg volume, 5 days are for Siteone Landscape Supply Incorporated (NYSE:SITE)’s short sellers to cover SITE’s short positions. About 124,042 shares traded. SiteOne Landscape Supply Inc (NYSE:SITE) has risen 73.63% since July 5, 2016 and is uptrending. It has outperformed by 56.93% the S&P500.

Analysts await IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) to report earnings on July, 12. They expect $-0.05 EPS, up 37.50% or $0.03 from last year’s $-0.08 per share. After $-0.07 actual EPS reported by IntelliPharmaCeutics Intl Inc (USA) for the previous quarter, Wall Street now forecasts -28.57% EPS growth.

Intellipharmaceutics International Inc is a Canada pharmaceutical firm engaged in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. The company has market cap of $86.83 million. The Company’s Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of a range of existing and new pharmaceuticals. It currently has negative earnings. Based on this technology platform, it has developed various drug delivery systems and a pipeline of products, and product candidates in various stages of development, in therapeutic areas that include neurology and cardiovascular.

SiteOne Landscape Supply, Inc. is a national wholesale distributor of landscape supplies in the United States and Canada. The company has market cap of $2.13 billion. The Firm is a supplier of irrigation, landscape lighting, hardscapes, lawn care supplies, nursery stock, and landscape accessories to green industry professionals. It currently has negative earnings. As of October 2, 2016, the Company had over 450 stores.

Among 7 analysts covering SiteOne Landscape Supply (NYSE:SITE), 6 have Buy rating, 0 Sell and 1 Hold. Therefore 86% are positive. SiteOne Landscape Supply had 8 analyst reports since June 6, 2016 according to SRatingsIntel. RBC Capital Markets initiated SiteOne Landscape Supply Inc (NYSE:SITE) on Tuesday, June 7 with “Outperform” rating. The rating was initiated by Robert W. Baird with “Outperform” on Monday, June 6. As per Thursday, June 23, the company rating was maintained by RBC Capital Markets. The firm earned “Accumulate” rating on Monday, May 8 by Johnson Rice. Goldman Sachs initiated it with “Neutral” rating and $31 target in Monday, June 6 report. The firm has “Buy” rating given on Monday, June 6 by Deutsche Bank. The stock has “Buy” rating by Suntrust Robinson on Monday, June 6. UBS initiated it with “Buy” rating and $12 target in Monday, June 6 report.